Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: GNPX) | Delayed: 2.72 +0.09 (3.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.63 | 52 Week High | $ | |||
| Open | $2.67 | 52 Week Low | $ | |||
| Day High | $2.81 | P/E | N/A | |||
| Day Low | $2.61 | EPS | $ | |||
| Volume | 151,732 | |||||
